ClassID:

112566

C12Q1/37 - page 4 - CPC Classification

Classification description:

Measuring or testing processes involving enzymes, nucleic acids or microorganisms ; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase

Recent Application in this class:
#901
20130089881
2013-04-11

Test for non-septic hypovolemic shock

#902
20130079425
2013-03-28

Urokinase-Type Plasminogen Activator Protein /Plasminogen Activator Inhibitor Type-1 Protein Selected Reaction Monitoring Assay

#903
20130078661
2013-03-28

Compounds and Methods for FRET Based Measurement of Enzyme Activity

#904
20130078652
2013-03-28

Methods and kits for determining von Willebrand factor activity in the absence of ristocetin and for determining the activity of ADAMTS-13 protease

#905
20130078645
2013-03-28

BIOMARKERS

#906
20130072429
2013-03-21

ASSAYS AND METHODS USING BIOMARKERS

#907
20130071835
2013-03-21

Qualitative and Quantitative Analytical Method for Analyzing the Activity Type of an Enzyme that is Activated by Proteolysis

#908
20130052732
2013-02-28

DNA-DAMAGE-INDUCED PROTEOLYSIS

#909
20130040368
2013-02-14

IMMUNO-BASED BOTULINUM TOXIN SEROTYPE A ACTIVITY ASSAYS

#910
20130034570
2013-02-07

METHODS AND COMPOSITIONS FOR MODULATING PROSTASIN

#911
20130029878
2013-01-31

Method for assaying histone methylation enzyme activity

#912
20130023002
2013-01-24

USE OF A SUBSTRATE IN A METHOD FOR MEASURING THE ACTIVITY OF AVAILABLE PROTEOLYTIC ENZYMES

#913
20130023001
2013-01-24

USE OF A SUBSTRATE IN A METHOD FOR MEASURING THE ACTIVITY OF PROTEOLYTIC ENZYMES

#914
20130022992
2013-01-24

In vitro assay for quantifying clostridial neurotoxin activity

#915
20130022991
2013-01-24

CELL FREE CD4 QUANTITATION AND METHODS OF USE

#916
20130022611
2013-01-24

METHODS AND COMPOSITIONS FOR MODULATING HEPSIN ACTIVATION OF UROKINASE-TYPE PLASMINOGEN ACTIVATOR

#917
20130011925
2013-01-10

Method for separating peptides and proteins

#918
20130005666
2013-01-03

Reporter system for high throughput screening of compounds and uses thereof

#919
20120322093
2012-12-20

METHOD FOR THE DETERMINATION OF SEQUENCE VARIANTS OF POLYPEPTIDES

#920
20120322092
2012-12-20

Resonance energy transfer assay with synaptobrevin substrate moiety

#921
20120315263
2012-12-13

Pharmaceutical compositions containing protease and methods for the treatment of lysosomal storage diseases

#922
20120308551
2012-12-06

Protease screening methods and proteases identified thereby

#923
20120302649
2012-11-29

Method for screening ameliorants of dry skin caused by atopic dermatitis using bleomycin hydrolase activity as indicator

#924
20120301945
2012-11-29

PROTEASE SCREENING METHODS AND PROTEASES IDENTIFIED THEREBY

#925
20120288883
2012-11-15

Probe reagent for measurement of proteolytic activity

#926
20120288873
2012-11-15

Biomarkers for the detection and screening of down syndrome

#927
20120282640
2012-11-08

Methods of measuring cell viability in tissue engineered products

#928
20120276566
2012-11-01

MEDIUM FOR THE SPECIFIC DETECTION OF RESISTANT MICROORGANISMS

#929
20120276529
2012-11-01

Mutated SUMO isoforms and uses thereof

#930
20120276007
2012-11-01

IMAGING AGENTS AND METHODS OF IMAGING NAALADASE OR PSMA

#931
20120270252
2012-10-25

MEDIUM FOR THE SPECIFIC DETECTION OF RESISTANT MICROORGANISMS

#932
20120270249
2012-10-25

MEDIUM FOR THE SPECIFIC DETECTION OF RESISTANT MICROORGANISMS

#933
20120264153
2012-10-18

Method of detecting phytase activity or protease activity

#934
20120263745
2012-10-18

Antichlamydial agents

#935
20120258929
2012-10-11

AGENT THAT MODULATES PHYSIOLOGICAL CONDITION OF PESTS, INVOLVED IN INSECT PEPTIDYL-DIPEPTIDASE A ACTIVITY

#936
20120254924
2012-10-04

METHOD CIRCUIT AND SYSTEM FOR DETECTING A CONNECTION REQUEST WHILE MAINTAINING A LOW POWER MODE

#937
20120252878
2012-10-04

USE OF CATHEPSIN H

#938
20120244160
2012-09-27

IDENTIFICATION OF MODULATORS OF SERINE PROTEASE INHIBITOR KAZAL AND THEIR USE AS ANTI-CANCER AND ANTI-VIRAL AGENTS

#939
20120244140
2012-09-27

SCREENING METHOD FOR SUBSTANCE CAPABLE OF PROMOTING RECOVERY OF SKIN BARRIER FUNCTION TECHNICAL FIELD

#940
20120237955
2012-09-20

Methods for identifying inhibitors of botulinum neurotoxins

#941
20120230970
2012-09-13

Method for treating pervasive development disorders

#942
20120225444
2012-09-06

Methods and apparatus for fractionation-based chemical analyses

#943
20120225436
2012-09-06

Immuno-based botulinum toxin serotype A activity assays

#944
20120222142
2012-08-30

Gut flora-derived extracellular vesicles, and method for searching for a disease model, vaccine, and candidate drug and for diagnosis using the same

#945
20120219965
2012-08-30

MASP 2, a complement-fixing enzyme, and uses for it

#946
20120214860
2012-08-23

Method of regulating the expression level of survival of motor neuron 1

#947
20120214181
2012-08-23

ASSAY FOR PCSK9 INHIBITORS

#948
20120214170
2012-08-23

Cellular depletion of biomolecular targets

#949
20120207740
2012-08-16

Method for treating pervasive development disorders

#950
20120196310
2012-08-02

A-FUCOSYLATION DETECTION IN ANTIBODIES

#951
20120178909
2012-07-12

Screening strategies for the identification of binders

#952
20120178773
2012-07-12

Compositions comprising enzyme-cleavable oxycodone prodrug

#953
20120178772
2012-07-12

Compositions comprising enzyme-cleavable oxycodone prodrug

#954
20120178114
2012-07-12

METHODS AND DEVICES FOR DETECTING THROMBIN GENERATION

#955
20120172253
2012-07-05

Compositions and methods for identifying enzyme and transport protein inhibitors

#956
20120171192
2012-07-05

Methods and materials for modulating deubiquitinases and ubiquitinated polypeptides

#957
20120171144
2012-07-05

METHODS OF TREATING, REDUCING AND INHIBITING THE APPEARANCE OF AGEING IN THE SKIN

#958
20120164675
2012-06-28

Methods and kit for protease enzyme assays

#959
20120164657
2012-06-28

Method of detecting botulinum neurotoxin and antibodies that neutralize botulinum neurotoxin action

#960
20120164128
2012-06-28

MEANS AND METHODS FOR COUNTERACTING POLYQ EXPANSION DISORDERS

#961
20120157824
2012-06-21

MRI AND OPTICAL ASSAYS FOR PROTEASES

#962
20120156799
2012-06-21

Automated method and system for the analysis of total dietary fiber

#963
20120156709
2012-06-21

Electrochemical assay for the detection of enzymes

#964
20120156708
2012-06-21

Method for simultaneously determining multiple coagulation proteases

#965
20120156691
2012-06-21

Compounds and methods for protease detection

#966
20120149883
2012-06-14

Detection and quantification of modified proteins

#967
20120149045
2012-06-14

Luminescent live and dead cell assay

#968
20120149032
2012-06-14

Enzyme detection device

#969
20120144504
2012-06-07

CASPASE-8 AND SKIN DISEASE

#970
20120141628
2012-06-07

METHOD FOR THE PREVENTION OR REDUCTION OF HAZE IN BEVERAGES

#971
20120141373
2012-06-07

Antibodies and methods of use thereof

#972
20120136064
2012-05-31

Methods for screening to identify therapeutic agents for Alzheimer's disease and use thereof

#973
20120135443
2012-05-31

Rapid bed-side measurement of neutrophil elastase activity in biological fluids

#974
20120129248
2012-05-24

ASSAY TOOLS AND METHODS OF USE

#975
20120129203
2012-05-24

Peptidase substrates

#976
20120129202
2012-05-24

COMPOSITION FOR ASSAYING GLYCATED PROTEINS

#977
20120122136
2012-05-17

Self-immolative probes for enzyme activity detection

#978
20120122135
2012-05-17

Peptidase substrates

#979
20120122134
2012-05-17

Peptidase substrates

#980
20120122133
2012-05-17

Devices for the detection of the presence and/or activity of proteases in biological samples

#981
20120122128
2012-05-17

Immuno-based botulinum toxin serotype A activity assays

#982
20120122127
2012-05-17

Cleavage sensitive antibodies and methods of use thereof

#983
20120121573
2012-05-17

Treatment of pulmonary vascular remodeling with neprilysin

#984
20120115835
2012-05-10

METHODS FOR TREATMENT OF BACTERIAL INFECTIONS

#985
20120115177
2012-05-10

Compositions and Methods for Diagnosis of Shock

#986
20120115163
2012-05-10

MARKED PEPTIDES AND USE THEREOF FOR ASSAYING CIRCULATING IRAP

#987
20120115133
2012-05-10

Cyanine dyes

#988
20120115129
2012-05-10

Enzyme substrate comprising a functional dye and associated technology and methods

#989
20120114626
2012-05-10

Method for treating pervasive development disorders

#990
20120114562
2012-05-10

Method for treating pervasive development disorders

#991
20120107859
2012-05-03

Methods for early detection of blood disorders

#992
20120107857
2012-05-03

Di- and poly-ubiquitin deubiquitinase substrates and uses thereof

#993
20120103810
2012-05-03

Method for reducing the appearance of false positive bands in SDS-page analysis of proteolytic digestion of a sample

#994
20120100624
2012-04-26

OPTICAL REACTION MEASUREMENT DEVICE AND OPTICAL REACTION MEASUREMENT METHOD

#995
20120100564
2012-04-26

Prediction of Memapsin 2 Cleavage Sites

#996
20120094922
2012-04-19

SCREENING ASSAYS FOR AGENTS THAT ALTER INHIBITOR OF APOPTOSIS (IAP) PROTEIN REGULATION OF CASPASE ACTIVITY

#997
20120077223
2012-03-29

Method for single oxygen atom incorporation into peptides

#998
20120071344
2012-03-22

Compositions and methods for identifying enzyme and transport protein inhibitors

#999
20120065103
2012-03-15

Prolyl Endopeptidase Probes

#1000
20120046642
2012-02-23

Optical detector for use in therapy

#1001
20120046180
2012-02-23

Releasable nonvolatile mass-label molecules

#1002
20120045784
2012-02-23

Biotinidase assay

#1003
20120045781
2012-02-23

Pathology biomarker assay

#1004
20120045474
2012-02-23

Substrate peptide sequences for plague plasminogen activator and uses thereof

#1005
20120045449
2012-02-23

Compositions, methods and uses of alpha 1-antitrypsin for early intervention in bone marrow transplantation and treatment of graft versus host disease

#1006
20120040385
2012-02-16

Coagulogen raw material, process for producing the same, and method and apparatus for measuring physiologically active substance of biological origin using the same

#1007
20120034638
2012-02-09

Electrochemical assay for the detection of enzymatically active PSA

#1008
20120034226
2012-02-09

DIAGNOSTIC METHOD OF SKIN INFLAMMATORY DISEASE

#1009
20120028371
2012-02-02

METHOD AND KIT FOR DETECTING THE EARLY ONSET OF RENAL TUBULAR CELL INJURY

#1010
20120028266
2012-02-02

Discovery of candidate biomarkers of in vivo apoptosis by global profiling of caspase cleavage sites

#1011
20120021929
2012-01-26

Use of DPPIV/seprase as a marker for cancer

#1012
20120021923
2012-01-26

METHODS AND SYSTEMS TO DIAGNOSE A CONDITION IN AN INDIVIDUAL

#1013
20120021454
2012-01-26

Rapid FRET-based diagnosis of bacterial pathogens

#1014
20120020918
2012-01-26

IL-1F5 polypeptides

#1015
20120015389
2012-01-19

Method for measuring the activity of cathepsin B after de-inhibition

#1016
20120015379
2012-01-19

Diagnosis of infection based on detection of bacterial secreted biomarkers

#1017
20120010230
2012-01-12

METHODS AND COMPOSITIONS FOR IDENTIFICATION, ASSESSMENT AND TREATMENT OF CANCERS ASSOCIATED WITH HEDGEHOG SIGNALING

#1018
20120003678
2012-01-05

Fructosyl peptide oxidase

#1019
20120003662
2012-01-05

Methods and Kits for Detecting Mastitis

#1020
20110319293
2011-12-29

Synthetic protease substrates, assay methods using such substrates and kits for practicing the assay

#1021
20110312009
2011-12-22

Composition for assaying glycated proteins

#1022
20110311661
2011-12-22

Plant Extracts and Dermatological Uses Thereof

#1023
20110306071
2011-12-15

Compositions and Methods for Identifying Substrate Specificity of Inhibitors of Gamma Secretase

#1024
20110306035
2011-12-15

Methods and Compositions for Detection of a Pathogen, Disease, Medical Condition, or Biomarker Thereof

#1025
20110305783
2011-12-15

Method and pharmaceutical composition for treating psoriasis, squamous cell carcinoma and/or parakeratosis by inhibiting expression of squamous cell carcinoma-related antigen

#1026
20110294697
2011-12-01

SYSTEM FOR DETECTNG PROTEASE

#1027
20110294149
2011-12-01

Alzheimer's Disease Secretase, APP Substrates Therefor, and Uses Therefor

#1028
20110293631
2011-12-01

Treatment of chronic pelvic pain syndrome

#1029
20110283373
2011-11-17

Mutant protease biosensors with enhanced detection characteristics

#1030
20110281285
2011-11-17

Assay for Detecting Cathepsin K Activty in Bone, Cartilage and/or Soft Tissue

#1031
20110280859
2011-11-17

Preventing and treating sepsis

#1032
20110275524
2011-11-10

METHODS AND SYSTEMS TO DETECT AN ACTIVE PROTEASE IN A SAMPLE

#1033
20110275104
2011-11-10

Device and method for detection of humidity-compromised urine test strips

#1034
20110275088
2011-11-10

Use of EEF1A as biomarker and a method of screening MetAP2 inhibitors

#1035
20110269244
2011-11-03

LIGAND-DIRECTED COVALENT MODIFICATION OF PROTEIN

#1036
20110269162
2011-11-03

UBIQUITIN PROTEASOME SYSTEM PROFILING FOR DIAGNOSIS OF CHRONIC LIVER DISEASE

#1037
20110263816
2011-10-27

Metallopeptide catalysts

#1038
20110262948
2011-10-27

Methods of Quantifying Methotrexate Metabolites

#1039
20110262931
2011-10-27

MAST CELL CARBOXYPEPTIDASE AS A MARKER FOR ANAPHYLAXIS AND MASTOCYTOSIS

#1040
20110262360
2011-10-27

Compositions Comprising Enzyme-Cleavable Phenol-Modified Opioid Prodrugs and Inhibitors Thereof

#1041
20110262359
2011-10-27

COMPOSITIONS COMPRISING ENZYME-CLEAVABLE PRODRUGS OF ACTIVE AGENTS AND INHIBITORS THEREOF

#1042
20110262355
2011-10-27

COMPOSITIONS COMPRISING ENZYME-CLEAVABLE OPIOID PRODRUGS AND INHIBITORS THEREOF

#1043
20110256567
2011-10-20

Fluorescent cyclic peptides, preparation method thereof and use of these peptides for measuring the enzymatic activity of a protease enzyme

#1044
20110251075
2011-10-13

SYSTEM AND METHOD FOR THE ANALYSIS OF BODILY FLUIDS

#1045
20110245150
2011-10-06

TARGETS FOR TREATMENT OF CHLAMYDIAL INFECTIONS

#1046
20110244549
2011-10-06

Hepatitis C virus variants

#1047
20110244495
2011-10-06

METHOD FOR TESTING ALZHEIMER'S DISEASE BY MEASURING DEGRADATION RATE OF ß-AMYLOID IN BLOOD AND DIAGNOSTIC REAGENT

#1048
20110237644
2011-09-29

UBIQUITIN SPECIFIC PROTEASES RESPONSIBLE FOR MCL-1 STABILITY AND USES THEREOF

#1049
20110229922
2011-09-22

SCREENING ASSAYS FOR THE IDENTIFICATION OF BACE2 INHIBITORS

#1050
20110229906
2011-09-22

Means and methods for monitoring protease inhibitor antiretroviral therapy and guiding therapeutic decisions in the treatment of HIV/AIDS

#1051
20110229458
2011-09-22

Methods for selecting protease resistant polypeptides

#1052
20110218119
2011-09-08

Methods of screening an agent for an activity in an isolated eye of a teleost

#1053
20110213337
2011-09-01

Methods for the early diagnosis of ovarian cancer

#1054
20110213121
2011-09-01

Nanoparticle sensor for measuring protease activity and method for manufacturing the same

#1055
20110212030
2011-09-01

Nucleic acid ligand complexes

#1056
20110206704
2011-08-25

Methods and compositions for modulating hepatocyte growth factor activator

#1057
20110201015
2011-08-18

Method for measuring endotoxin and reagent kit for measuring endotoxin

#1058
20110195443
2011-08-11

Screening method for identifying protease secretion-deficient mutants of microorganisms

#1059
20110195442
2011-08-11

STERILITY INDICATING BIOLOGICAL COMPOSITIONS, ARTICLES AND METHODS

#1060
20110190142
2011-08-04

DETERMINATION OF RENIN-PRORENIN RECEPTOR ACTIVITY

#1061
20110183891
2011-07-28

Methods and Compositions for Inhibiting Fungal Infection and Disease

#1062
20110183366
2011-07-28

Methods for achieving a protective ACE2 expression level to treat kidney disease and hypertension

#1063
20110183357
2011-07-28

Device and methods for liquid crystal-based bioagent detection

#1064
20110183328
2011-07-28

Detecting neoplasm

#1065
20110182815
2011-07-28

METHOD FOR THE DETECTION OF ENZYMATIC ACTIVITY WITH MAGNETICALLY FUNCTIONALIZED SUBSTRATES

#1066
20110178027
2011-07-21

Multi-LEU peptides and analogues thereof as selective PACE4 inhibitors and effective antiproliferative agents

#1067
20110177491
2011-07-21

PEPTIDE FOR USE IN SIMULTANEOUS PROTEIN QUANTIFICATION OF METABOLIZING ENZYMES USING MASS SPECTROMETRIC ANALYSIS APPARATUS

#1068
20110171675
2011-07-14

FRET-BASED MEMBRANE-TYPE 1 MATRIX METALLOPROTEINASE BIOSENSOR AND METHODS FOR USING THE SAME

#1069
20110171196
2011-07-14

METHODS OF TREATMENT AND USES FOR CAMKII AND ITS INTERACTION WITH HDACS AND CALPAIN

#1070
20110165607
2011-07-07

METHOD FOR EVALUATING STATUS OF SKIN BARRIER FUNCTION OF NATURAL MOISTURIZING FACTOR USING BLEOMYCIN HYDROLASE ACTIVITY AS INDICATOR

#1071
20110165603
2011-07-07

SMALL MOLECULE FLUORESCENT SENSORS FOR DETECTION OF POST-TRANSLATIONALMODIFICATIONS AND PROTEIN INTERACTIONS IN BIOASSAYS

#1072
20110152341
2011-06-23

CLEAVAGE OF B-AMYLOID PRECURSOR PROTEIN

#1073
20110152340
2011-06-23

Methods for Identifying Subjects With an Increased Likelihood of Responding to DPP-IV Inhibitors

#1074
20110143420
2011-06-16

Kit for single oxygen atom incorporation into digested peptides

#1075
20110143385
2011-06-16

PLASMA MEMBRANE VESICLES AND METHODS OF MAKING AND USING SAME

#1076
20110143379
2011-06-16

Detection and quantitation of full-length thioredoxin (TRX) and truncated thioredoxin (TRX 80) in complex samples

#1077
20110143369
2011-06-16

Method for determining treatment of disseminated intravascular coagulation

#1078
20110143362
2011-06-16

METHOD FOR IDENTIFICATION OF PROTEASE ACTIVITY INHIBITORS AND ASSAYING THE PRESENCE OF PROTEASE ACTIVITY

#1079
20110136730
2011-06-09

"Method for screening compounds comprising the use of picornavirus protease 2A"

#1080
20110130338
2011-06-02

USE OF SERINE PROTEASE INHIBITORS IN THE TREATMENT OF SKIN DISEASES

#1081
20110124520
2011-05-26

Compositions and Methods for Spatial Separation and Screening of Cells

#1082
20110118338
2011-05-19

METHODS, COMPOSITIONS AND COMPOUND ASSAYS FOR INHIBITING AMYLOID-BETA PROTEIN PRODUCTION

#1083
20110118140
2011-05-19

METHODS FOR IDENTIFICATION, AND COMPOUNDS USEFUL FOR THE TREATMENT OF DEGENERATIVE & INFLAMMATORY DISEASES

#1084
20110111444
2011-05-12

Kit for assaying EphA4 processing by gamma-secretase

#1085
20110104171
2011-05-05

EphA4 Polypeptide Having a Novel Activity and Use Thereof

#1086
20110104075
2011-05-05

Xe biosensors and their use

#1087
20110098227
2011-04-28

Soluble notch-based substrates for gamma secretase and methods and compositions for using same

#1088
20110097758
2011-04-28

Peptide conjugates and fluorescence detection methods for intracellular caspase assay

#1089
20110091920
2011-04-21

METHOD OF DIAGNOSING A CLINICAL CONDITION BY DETECTION OF A PAPP-A/proMBP COMPLEX

#1090
20110091888
2011-04-21

Cathepsin C-based screening methods for identifying modulators of pain

#1091
20110086370
2011-04-14

Protease detection

#1092
20110086056
2011-04-14

Methods for the early diagnosis of ovarian cancer

#1093
20110086006
2011-04-14

HCV NS3-NS4 Protease Resistance Mutants

#1094
20110082048
2011-04-07

Systematic evaluation of sequence and activity relationships using site evaluation libraries for engineering multiple properties

#1095
20110076709
2011-03-31

Method for the Diagnosis of Leukemia Using Caspase-3

#1096
20110070594
2011-03-24

Method for detecting

#1097
20110065127
2011-03-17

Detection of degradative enzymes in bodily fluids

#1098
20110065122
2011-03-17

METHOD FOR ACCESSING MICROBIAL DIVERSITY

#1099
20110064657
2011-03-17

Labeled inhibitors of prostate specific membrane antigen (PSMA), biological evaluation, and use as imaging agents

#1100
20110059474
2011-03-10

Method for determining carbohydrate and kit for determining carbohydrate

#1101
20110059465
2011-03-10

Screening assays for agents that alter inhibitor of apoptosis (IAP) protein regulation of caspase activity

#1102
20110059065
2011-03-10

FUNCTION AND REGULATION OF ADAMTS-1

#1103
20110058164
2011-03-10

Real-time, single-step bioassay using nanoplasmonic resonator with ultra-high sensitivity

#1104
20110054165
2011-03-03

Xanthene dyes

#1105
20110053791
2011-03-03

Method for detecting or determining abnormal prion protein associated with transmissible spongiform encephalopathy in blood-derived specimen or body fluid-derived specimen

#1106
20110053199
2011-03-03

UBIQUITIN PROTEASOME SYSTEM PROFILING AND THE USE THEREOF IN CLINICAL APPLICATIONS FOR CANCER DIAGNOSIS

#1107
20110053198
2011-03-03

UBIQUITIN PROTEASOME SYSTEM PROFILING AND THE USE THEREOF IN CLINICAL APPLICATIONS FOR PROLIFERATIVE HEMATOLOGICAL DISORDERS

#1108
20110053197
2011-03-03

UBIQUITIN PROTEASOME SYSTEM PROFILING AND THE USE THEREOF IN CLINICAL APPLICATIONS FOR CANCER DIAGNOSIS

#1109
20110053174
2011-03-03

Magnetic-nanoparticle conjugates and methods of use

#1110
20110052572
2011-03-03

REGULATORS OF MMP-9 AND USES THEROF

#1111
20110046044
2011-02-24

Use of a cysteine protease of Plasmodium vivax

#1112
20110046004
2011-02-24

Magnetic-nanoparticle conjugates and methods of use

#1113
20110045515
2011-02-24

METHOD TO DETECT HEMOLYTIC STREPTOCOCCUS AND OPTOELECTRICALLY DETERMINE RESULTS

#1114
20110045512
2011-02-24

Time-course measurement of enzymatic activity corrected for impacts of disturbances relating to the reaction of the enzyme with a substrate

#1115
20110039289
2011-02-17

FLUOROGENIC PEPTIDES AND THEIR METHOD OF PRODUCTION

#1116
20110039288
2011-02-17

Reaction medium for methicillin-resistant (MRSA) bacteria

#1117
20110033866
2011-02-10

Resonance energy transfer assay with cleavage sequence and spacer

#1118
20110014125
2011-01-20

Protease assay

#1119
20110008869
2011-01-13

Engineered proteases for affinity purification and processing of fusion proteins

#1120
20110008789
2011-01-13

METHODS AND MATERIALS FOR TREATING INFLAMMATORY CONDITIONS

#1121
20110003312
2011-01-06

Linked peptides fluorogenic biosensors

#1122
20100331266
2010-12-30

Analysis of amino acid copolymer compositions

#1123
20100330599
2010-12-30

Methods to identify USP1 deubiquitinating enzyme complex inhibitors

#1124
20100324114
2010-12-23

Methods and kits to detect hereditary angioedema type III

#1125
20100323377
2010-12-23

Biochemical markers for CVD risk assessment

#1126
20100320093
2010-12-23

Protease detection assay

#1127
20100317044
2010-12-16

Mass spectrometric endopeptidase assay

#1128
20100310635
2010-12-09

Compositions and Methods for Regulating T-Cell Activity

#1129
20100310540
2010-12-09

METHODS OF SCREENING FOR COMPOUNDS THAT MODULATE TAFIA ACTIVITY, COMPOUNDS, AND METHODS OF USING THE COMPOUNDS

#1130
20100304404
2010-12-02

MOLECULAR MODIFICATION ASSAYS

#1131
20100303728
2010-12-02

CASPASE IMAGING PROBES

#1132
20100297683
2010-11-25

Method for detecting a protease

#1133
20100297620
2010-11-25

Activated protease indicator

#1134
20100292298
2010-11-18

METHOD AND REAGENTS FOR TREATING HEPATIC FIBROSIS AND INFLAMMATION

#1135
20100292174
2010-11-18

Caspase inhibitors in the treatment of infection-associated preterm delivery

#1136
20100292129
2010-11-18

Methods and Compositions for Enhancing Proteasome Activity

#1137
20100291596
2010-11-18

SCREENING METHOD FOR AGENTS SUITABLE FOR THERAPY OF ALZHEIMER'S DISEASE

#1138
20100290987
2010-11-18

Methods and compositions for detections and modulating O-glycosylation

#1139
20100285017
2010-11-11

Matriptase protein and uses thereof

#1140
20100273943
2010-10-28

PEPTIDE CONJUGATES AND FLUORESCENCE DETECTION METHODS FOR INTRACELLULAR CASPASE ASSAY

#1141
20100273181
2010-10-28

Methods for the detection of glycated hemoglobin

#1142
20100272709
2010-10-28

Cathepsin L mediated diseases and associated methods and products

#1143
20100267609
2010-10-21

COMPOUNDS WHICH INHIBIT BETA-SECRETASE ACTIVITY AND METHODS OF USE THEREOF

#1144
20100267054
2010-10-21

Method for measuring the activity of proteases

#1145
20100261216
2010-10-14

STABILITY TESTING OF ANTIBODIES

#1146
20100261214
2010-10-14

Method for determining ACE2 activity

#1147
20100249427
2010-09-30

Bioluminescent protease assay

#1148
20100240083
2010-09-23

METHOD FOR THE DETECTION OF THE IN-VIVO ACTIVITY OF NEUROTRYPSIN, USE OF THE METHOD AND USE OF THE C-TERMINAL, 22-KDA FRAGMENT OF AGRIN AS BIOMARKER IN DIAGNOSIS AND MONITORING OF NEUROTRYPSIN-RELATED DISTURBANCES

#1149
20100240050
2010-09-23

Methods and products for in vivo enzyme profiling

#1150
20100234463
2010-09-16

Method for Identifying Modulators of Gamma Secretase or Notch

#1151
20100233743
2010-09-16

Bisubstrate fluorescent probe binding to protein kinases

#1152
20100233741
2010-09-16

Immuno-based retargeted endopeptidase activity assays

#1153
20100233728
2010-09-16

METHOD AND KIT FOR DETECTING THE EARLY ONSET OF RENAL TUBULAR CELL INJURY

#1154
20100233726
2010-09-16

Method for determining the presence of an enzyme in a sample

#1155
20100227418
2010-09-09

METHOD AND KIT FOR DETECTING THE EARLY ONSET OF RENAL TUBULAR CELL INJURY

#1156
20100227345
2010-09-09

Enzyme containing liquid and delivery system for detection of analytes on surfaces

#1157
20100222429
2010-09-02

Enzymatic methods and enzymes

#1158
20100222233
2010-09-02

AFFINITY CAPTURE OF PEPTIDES BY MICROARRAY AND RELATED METHODS

#1159
20100216177
2010-08-26

METHOD AND KIT FOR UNIVERSAL VERIFICATION OF ENZYME ACTIVITY AND PROTEIN DIGESTION

#1160
20100210022
2010-08-19

Methods of detecting mastitis by levels of proteasomes

#1161
20100209956
2010-08-19

METHODS AND COMPOSITIONS FOR MODULATING HEPATOCYTE GROWTH FACTOR ACTIVATION

#1162
20100209954
2010-08-19

METHOD OF IDENTIFICATION AND QUANTIFICATION OF PROTEINS, ISOFORMS OF THE ANGIOTENSIN I CONVERTING ENZYME, MOLECULAR GENETIC MARKER BASED ON SAID PROTEINS, USE OF MENTIONED MARKER, ANALYTICAL METHOD FOR DIAGNOSIS, RISK STRATIFICATION, THERAPEUTICAL DECISION IN CARRIERS OF ARTERIAL HYPERTENSION AND RENAL LESION AND KIT FOR USING IN THE DIAGNOSIE

#1163
20100209943
2010-08-19

Measurement Of Protease Activity In Post-Mortem Meat Samples

#1164
20100209940
2010-08-19

Fibrosis biomarker assay

#1165
20100209436
2010-08-19

METHOD FOR TREATING DISEASES RELATED TO MITOCHONDRIAL DYSFUNCTION

#1166
20100204054
2010-08-12

Methods for identifying inhibitors of botulinum neurotoxins

#1167
20100203559
2010-08-12

Immuno-based botulinum toxin serotype A activity assays

#1168
20100196367
2010-08-05

Methods for screening candidate agents for modulating prorenin and renin, assays for detecting prorenin and antibodies

#1169
20100190184
2010-07-29

SCREENING METHOD UTILIZING NOVEL SUBSTRATE C-RET FOR GAMMA-SECRETASE

#1170
20100189658
2010-07-29

Imaging probes

#1171
20100184709
2010-07-22

Malt1 specific cleavage in assay and screening method

#1172
20100184112
2010-07-22

Ligand binding stabilization method for drug target identification

#1173
20100184106
2010-07-22

Thrombin substrate and assay for determining the level of bioactive thrombin in a sample

#1174
20100178659
2010-07-15

Method of measuring HbA1c

#1175
20100178287
2010-07-15

USE OF COAGULATION PROTEINS TO LYSE CLOTS

#1176
20100173977
2010-07-08

Crystal structure of the N-terminal domain of angiotensin converting enzyme and uses thereof

#1177
20100173972
2010-07-08

METHODS AND USES RELATED TO RHBDL4

#1178
20100173349
2010-07-08

Cellular libraries of peptide sequences (CLiPS) and methods of using the same

#1179
20100168089
2010-07-01

UTILIZATION OF TACE INHIBITORS FOR THE TREATMENT OF ACNE

#1180
20100167270
2010-07-01

METAPNEUMOVIRUS STRAINS AND THEIR USE IN VACCINE FORMULATIONS AND AS VECTORS FOR EXPRESSION OF ANTIGENIC SEQUENCES AND METHODS FOR PROPAGATING VIRUS

#1181
20100160171
2010-06-24

Methods For Detection Of Sepsis

#1182
20100159493
2010-06-24

METHODS OF QUANTIFYING METHOTREXATE METABOLITES

#1183
20100151499
2010-06-17

PROTEOLYTIC RELEASE OF GLYCANS

#1184
20100151494
2010-06-17

FRET protease assays for clostridial toxins

#1185
20100151489
2010-06-17

Method for quantifying biomolecules conjugated to a nanoparticle

#1186
20100151484
2010-06-17

Kinase and ubiquination assays

#1187
20100144634
2010-06-10

Compositions and Methods for Modulation of ADAMTS13 Activity

#1188
20100144623
2010-06-10

C-terminal domain truncation of mGluR1α by calpain and uses thereof

#1189
20100143957
2010-06-10

Methods of measuring ADAMTS13-mediated in vivo cleavage of von Willebrand factor and uses thereof

#1190
20100143945
2010-06-10

DNA-damage-induced proteolysis

#1191
20100143937
2010-06-10

ASSAY METHODS FOR IDENTIFYING AGENTS THAT MODIFY THE ACTIVITY OF NAPE-PLD OR Abh4

#1192
20100143888
2010-06-10

ENZYMATIC DIAGNOSTIC TEST FOR SARS AND OTHER VIRAL DISEASES

#1193
20100136594
2010-06-03

High-throughput assay for evaluating dipeptidyl peptidase I activity

#1194
20100136589
2010-06-03

Methods and kits for determining von willebrand factor activity in the absence of ristocetin

#1195
20100136567
2010-06-03

Cyanine dyes

#1196
20100136010
2010-06-03

Novel 27875, 22025, 27420, 17906, 16319, 55092 and 10218 molecules and uses therefor

#1197
20100129933
2010-05-27

METHOD FOR DETECTING THE BINDING BETWEEN MDM2 AND THE PROTEASOME

#1198
20100129814
2010-05-27

Method for separation and characterization of microorganisms using identifier agents

#1199
20100124757
2010-05-20

Gold nanoparticle based protease imaging probes and use thereof

#1200
20100120133
2010-05-13

Separation device for use in the separation, characterization and/or identification of microorganisms